Skip to content
Review Open access

Reducing Drug-Related Problems and Optimising Therapy in Older Adults with Polypharmacy: A Systematic Review of Community Pharmacy-Based Medication Reviews

Oct 2026 · Istanbul Journal of Pharmacy · Vol 56, pp. 250-260 · 0 citations · 26 references

TL;DR

Overall, pharmacist-led medication review appears to be a promising strategy to support safer and more appropriate medication use among older adults with polypharmacy, although further well-designed studies are needed to clarify long-term clinical, humanistic, and economic outcomes.

Abstract

Background and Aims: Polypharmacy is increasingly common among older adults, particularly those living with multiple chronic conditions, and is associated with a greater risk of drug-related problems (DRPs), inappropriate prescribing, and poor treatment adherence. This systematic review synthesised evidence on the effects of pharmacist-led medication review (MR) interventions on DRPs, medication adherence, deprescribing, and selected clinical outcomes among older adults with polypharmacy.Methods: The review was conducted in accordance with Cochrane guidance and PRISMA recommendations. Scopus, MEDLINE (EBSCO), and ScienceDirect were searched for interventional studies published between 2020 and 2025. Eligible studies included adults with polypharmacy (commonly defined as the use of five or more medications) who received pharmacist-led structured MR in community pharmacy or related primary care settings and reported quantitative outcomes. Study selection, data extraction, and methodological appraisal using Joanna Briggs Institute tools were independently undertaken by two reviewers.Results: Twenty-three studies were included, most of which were randomised or controlled interventional studies. Across the included studies, pharmacist-led MR interventions were generally associated with reductions in DRPs, improvements in medication adherence, and greater prescribing optimisation, including deprescribing of potentially inappropriate or high-risk medicines. Some studies also reported improvements in selected clinical indicators and potential economic benefits. However, the evidence was heterogeneous regarding study design, intervention components, outcome measures, and methodological quality.Conclusion: Overall, pharmacist-led medication review appears to be a promising strategy to support safer and more appropriate medication use among older adults with polypharmacy, although further well-designed studies are needed to clarify long-term clinical, humanistic, and economic outcomes.

Read PDF

Similar papers

Review Open access Oct 2026

Structured medication reviews for adults with multimorbidity and polypharmacy in primary care: a systematic review

Abstract Objectives Structured medication reviews (SMRs) in primary care offer a patient-centred approach to optimising medicines for adults with multimorbidity and polypharmacy, but their effect on endpoint outcomes is not yet well-established. This review summarises their impact on these outcomes and on medicines opt...

Elena Lammila-Escalera, G. Greenfield, R. Aldakhil et al. · 0 citations
Review Open access Oct 2026

A Narrative Review of Medication Optimisation in Older Adults with Polypharmacy: From Structured Medication Review to AI-Enabled Medication Safety

Context: Polypharmacy, commonly defined as the concurrent use of five or more medicines, and excessive polypharmacy, often defined as the use of ten or more medicines, are highly prevalent among older adults with multimorbidity. Although appropriate polypharmacy may be necessary, polypharmacy can be associated with adv...

R. Aro, Z. Wojszel, P. Duez et al. · 1 citation
Review Open access Oct 2026

Multidisciplinary Clinical Pharmacology in Complex Pharmacotherapy: Drug-Related Errors, Pharmacovigilance, and Evidence-Based Strategies for Medication Safety—A Systematic Review and Meta-Analysis

Background: Complex pharmacotherapy has become a defining feature of modern clinical care, particularly in older adults, patients with multimorbidity, and those moving across care settings. As the number of prescribed medicines increases, so does the risk of drug-related errors, adverse drug reactions, inappropriate pr...

N. Sulashvili, Margarita Beglaryan, N. Alavidze et al. · 0 citations
Review Oct 2026

Efficacy and Safety of Pharmacist-Led Medication Therapy Management in Patients with Multimorbidity: A Systematic Review

Background: Multimorbidity contributes to treatment burden and medication-related harm in adults. Pharmacist-led services address these challenges, but evidence remains heterogeneous. Aim: To synthesise evidence on pharmacist-led medication management for adults with multimorbidity and integrate core components into a...

Abdulrahman Mohammad Alghamdi · 0 citations
Review 2026

Prevalence of polypharmacy and potentially inappropriate medication use among older adults receiving home health care: a systematic review and meta-analysis

Home health care serves some of the oldest, most multimorbid community-dwelling adults, but the burden of polypharmacy and potentially inappropriate medication (PIM) use in this population has not been systematically quantified. This study aimed to estimate this prevalence and summarize associated determinants and clin...

F. Alghamdi, Obai Mesawa, Sara A. A. Aljuhani et al. · 0 citations
Review Open access Oct 2026

Structured medication reviews for polypharmacy: evidence and implementation across Europe

Abstract Background Polypharmacy, defined as the long-term use of five or more medicines, is prevalent in ageing populations and associated with drug-related problems such as adverse drug events, drug interactions, inappropriate prescribing and reduced adherence. Structured medication reviews (SMR) are proposed to opti...

R. Jeindl, J. Kern-Kim, C. Strohmaier et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.